should you change injection sites for semaglutide (Ozempic) Side Effects & Management Where to Inject Semaglutide: Abdomen,

The study is the latest in a series of trials to show potential benefits beyond diabetes control and weight loss for semaglutide, the main ingredient in both Novos Ozempic and its obesity medicine Wegovy

A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist

The clinical trial data showed that using a lower starting dose (2 mg vs 4 mg initial) significantly reduced the incidence and severity of these symptoms

You have a BMI of 27 or higher plus a weight-related comorbidity approved by Cigna, including (but not limited to) hypertension, Type 2 diabetes, obstructive sleep apnea, and CV disease